National Hepatitis C Testing Policy May 2007
Abbreviations
- Executive Summary
- Introduction
- 1. Guiding principles for hepatitis C testing
- 2. Indications for hepatitis C testing
- 3. Transmission and infection control in the healthcare setting
- 4. Aboriginal and Torres Strait Islander People
- 5. Surveillance and research
- 6. Access to diagnostic testing
- 7. Pre-test and post-test discussions
- 8. Diagnostic strategies
- 9. Quality assuring hepatitis C Testing
- 10. Funding
Appendices- Glossary
- Abbreviations
ALT: alanine aminotransferase
APHDPC: Australian Population Health Development Principal Committee
BBVSS: Blood Borne Virus and Sexually Transmissible Infections Subcommittee of the APHDPC.
CALD: Culturally and Linguistically Diverse
CDNA: Communicable Diseases Network of Australia
EIA: enzyme immuno-assay
EPP: Exposure Prone Procedure
HCV: hepatitis C virus
HIV: human immunodeficiency virus
IDU: injecting drug use
IGCAHRD: Intergovernmental Committee on AIDS, Hepatitis C and Related Diseases
IVD: in-vitro diagnostic device
LFT: liver function test
MBS: Medicare Benefits Schedule
MSAC: Medicare Services Advisory Committee
NAT: nucleic acid test/testing
NATA: National Association of Testing Authorities
NHMRC: National Health and Medical Research Council
NPAAC: National Pathology Accreditation Advisory Committee
NRL: National Serology Reference Laboratory, Australia
PCR: polymerase chain reaction
PHLN: Public Health Laboratory Network
RCPA: Royal College of Pathologists of Australasia
RNA: ribonucleic acid
TGA: Therapeutic Goods Administration